Damian Handisides

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial

Rinaldo Bellomo, Lui G. Forni, Laurence W. Busse et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 215 citations · Full text

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

Jinsong Hu, Damian Handisides, Els Van Valckenborgh et al. · Blood · 2010 · 155 citations

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

Rinaldo Bellomo, Richard G. Wunderink, Harold M. Szerlip et al. · Critical Care · 2020 · 121 citations · Full text

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, <i>In Vivo</i> and <i>In Vitro</i>

Jinsong Hu, Els Van Valckenborgh, Dehui Xu et al. · Molecular Cancer Therapeutics · 2013 · 54 citations · Full text

Apoptosis, Immunology, Cell Death +17

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

Jacob P. Laubach, Chia‐Jen Liu, Noopur Raje et al. · Clinical Cancer Research · 2018 · 42 citations · Full text